EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
    2.1.1.5 | Abruptio Placentae |
17376725 |
Polymorphisms in methionine synthase reductase and betaine-homocysteine S-methyltransferase genes: risk of placental abruption. |
causal interaction
diagnostic usage
unassigned |
2
3
0 |
| 2.1.1.5 | Adenoma |
17389618 |
Twenty-four non-synonymous polymorphisms in the one-carbon metabolic pathway and risk of colorectal adenoma in the Nurses' Health Study. |
causal interaction
diagnostic usage
unassigned |
3
1
0 |
| 2.1.1.5 | Anencephaly |
17035141 |
Neural tube defects and folate pathway genes: family-based association tests of gene-gene and gene-environment interactions. |
ongoing research
unassigned |
3
0 |
| 2.1.1.5 | Atherosclerosis |
1819467 |
Betaine:homocysteine methyltransferase--a new assay for the liver enzyme and its absence from human skin fibroblasts and peripheral blood lymphocytes. |
causal interaction
unassigned |
4
0 |
| 2.1.1.5 | betaine-homocysteine s-methyltransferase deficiency |
22362777 |
Mouse betaine-homocysteine S-Methyltransferase deficiency reduces body fat via increasing energy expenditure and impairing lipid synthesis and enhancing glucose oxidation in white adipose tissue. |
ongoing research
unassigned |
2
0 |
| 2.1.1.5 | betaine-homocysteine s-methyltransferase deficiency |
23014492 |
Homocysteinemia in mice with genetic betaine homocysteine S-methyltransferase deficiency is independent of dietary folate intake. |
causal interaction
ongoing research
unassigned |
4
2
0 |
| 2.1.1.5 | betaine-homocysteine s-methyltransferase deficiency |
30753104 |
Betaine-homocysteine S-methyltransferase deficiency causes increased susceptibility to noise-induced hearing loss associated to plasma hyperhomocysteinemia. |
causal interaction
unassigned |
4
0 |
| 2.1.1.5 | Breast Neoplasms |
27488260 |
Dietary choline and betaine intake, choline-metabolising genetic polymorphisms and breast cancer risk: a case-control study in China. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
2
1
3
2 |
| 2.1.1.5 | Breast Neoplasms |
31889940 |
The plasma peptides of breast versus ovarian cancer. |
unassigned |
0 |
| 2.1.1.5 | Carcinoma |
21556466 |
L-arginine-glycine amidinotransferase, betaine-homocysteine S-methyltransferase, and neuropolypeptide H3 are diminished in renal clear cell carcinoma of humans. |
ongoing research
unassigned |
1
0 |
